Non-Melanoma Skin Cancer Clearance after Medical Treatment Detected with Noninvasive Skin Imaging: A Systematic Review and Meta-Analysis.
basal cell carcinoma
dermoscopy
non-melanoma skin cancer
nonsurgical treatment
optical coherence tomography
reflectance confocal microscopy
squamous cell carcinoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Jun 2022
08 Jun 2022
Historique:
received:
07
04
2022
revised:
24
05
2022
accepted:
05
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Non-melanoma skin cancer (NMSC) treated with nonsurgical therapies can be monitored with noninvasive skin imaging. The precision of dermoscopy, reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) in detecting clearance is unclear. We aim to report the proportion of persisting tumors identified with noninvasive technologies available in the literature. A systematic literature search was conducted on the PubMed and Cochrane Public Library Databases for articles published prior to November 2021. Statistical analyses were conducted with MedCalc 14.8.1 software. A total of eight studies (352 lesions) reporting noninvasive imaging for NMSC clearance following nonsurgical treatment were included. Most ( Routine clinical examination and dermoscopy underperform when employed for NMSC clearance monitoring, although they represent the first approach to the patient. OCT and RCM seem to improve the detection of persistent BCC after medical treatment.
Sections du résumé
BACKGROUND/OBJECTIVES
OBJECTIVE
Non-melanoma skin cancer (NMSC) treated with nonsurgical therapies can be monitored with noninvasive skin imaging. The precision of dermoscopy, reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) in detecting clearance is unclear. We aim to report the proportion of persisting tumors identified with noninvasive technologies available in the literature.
METHODS
METHODS
A systematic literature search was conducted on the PubMed and Cochrane Public Library Databases for articles published prior to November 2021. Statistical analyses were conducted with MedCalc 14.8.1 software.
RESULTS
RESULTS
A total of eight studies (352 lesions) reporting noninvasive imaging for NMSC clearance following nonsurgical treatment were included. Most (
CONCLUSIONS
CONCLUSIONS
Routine clinical examination and dermoscopy underperform when employed for NMSC clearance monitoring, although they represent the first approach to the patient. OCT and RCM seem to improve the detection of persistent BCC after medical treatment.
Identifiants
pubmed: 35740502
pii: cancers14122836
doi: 10.3390/cancers14122836
pmc: PMC9221328
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Dermatol Surg. 2015 Nov;41(11):1214-40
pubmed: 26445288
Photodiagnosis Photodyn Ther. 2016 Jun;14:178-84
pubmed: 27109055
Photodiagnosis Photodyn Ther. 2010 Mar;7(1):24-32
pubmed: 20230990
Photodiagnosis Photodyn Ther. 2017 Jun;18:133-137
pubmed: 28179181
G Ital Dermatol Venereol. 2015 Aug;150(4):393-405
pubmed: 26184797
J Eur Acad Dermatol Venereol. 2018 May;32(5):763-767
pubmed: 29055164
Dtsch Arztebl Int. 2014 May 30;111(22):389-95
pubmed: 24980564
Br J Dermatol. 2012 Feb;166(2):451-3
pubmed: 21824125
Dermatol Clin. 2019 Oct;37(4):435-441
pubmed: 31466584
Clin Exp Dermatol. 2021 Dec;46(8):1530-1541
pubmed: 34115900
Eur J Dermatol. 2012 Jul-Aug;22(4):456-63
pubmed: 22534287
Dermatol Surg. 2015 May;41(5):550-71
pubmed: 25868035
Hematol Oncol Clin North Am. 2019 Feb;33(1):13-24
pubmed: 30497670
Br J Dermatol. 2014 Apr;170(4):809-15
pubmed: 24283541
Clin Oncol (R Coll Radiol). 2019 Nov;31(11):759-768
pubmed: 31522944
Acta Derm Venereol. 2016 Jan;96(1):64-7
pubmed: 26073523
Curr Treat Options Oncol. 2018 Sep 20;19(11):56
pubmed: 30238167
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1771-80
pubmed: 25712021
JAMA Dermatol. 2018 Oct 1;154(10):1175-1183
pubmed: 30140851
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Australas J Dermatol. 2022 Feb;63(1):15-26
pubmed: 34423852
Skin Res Technol. 2014 May;20(2):170-6
pubmed: 24103017
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):772-778
pubmed: 35141952
Dermatology. 2012;225(3):264-70
pubmed: 23257915
Arch Dermatol. 2006 Jun;142(6):729-35
pubmed: 16785375
Br J Dermatol. 2012 Dec;167(6):1382-5
pubmed: 22759263
Am J Dermatopathol. 2018 Mar;40(3):173-179
pubmed: 28816741
J Am Acad Dermatol. 2019 Feb;80(2):321-339
pubmed: 29782901
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1828-1833
pubmed: 28696052
Dermatol Surg. 2021 May 1;47(5):609-612
pubmed: 33905391
Br J Dermatol. 2013 Jan;168(1):99-105
pubmed: 23013443
Arch Dermatol. 2010 Mar;146(3):283-7
pubmed: 20231499
Sci Rep. 2021 Nov 30;11(1):23124
pubmed: 34848749